ISPOR Code Of Ethics Task Force

The ISPOR New Code of Ethics Task Force has completed a revised version of the original code that was approved by the ISPOR Board of Directors in 2003. To see the orginal ISPOR Code of Ethics please see http://www.ispor.org/TaskForces/code_ethics0103.asp or pdf format.

The Task Force and the ISPOR Board of Directors are asking for the membership to review and comment on the revised code. Please review the following new Code of Ethics and submit your comments to code@ispor.org. The review period is from Monday, August 27, 2007 through Thursday, September 27, 2007

Task Force Chair:
Francis Palumbo PhD, JD, Professor and Executive Director, University of Maryland School of Pharmacy Center on Drugs & Public Policy, Baltimore, Maryland, USA

Task Force Members:
Rod Barnes, MBA, Senior Director, Health Economics, Alcon Laboratories, Inc., Fort Worth, Texas, USA
Michael Iskedjian RPh, MSc, President, PharmIdeas Research & Consulting, Inc., Oakville, ON, Canada
William McGhan, PharmD, PhD, Professor, University of the Sciences in Philadelphia, Pennsylvania, USA
David Miller, PhD, Vice President of Pharmacoeconomics & Site Head, Elan Pharma Ltd., Stevenage, Herts, UK
Richard Milne PhD, Associate Professor, University of Auckland, New Zealand
Albert Wertheimer, MBA, PhD, Professor, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA

NEW ISPOR CODE OF ETHICS